CL2008001795A1 - Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial. - Google Patents

Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial.

Info

Publication number
CL2008001795A1
CL2008001795A1 CL200801795A CL2008001795A CL2008001795A1 CL 2008001795 A1 CL2008001795 A1 CL 2008001795A1 CL 200801795 A CL200801795 A CL 200801795A CL 2008001795 A CL2008001795 A CL 2008001795A CL 2008001795 A1 CL2008001795 A1 CL 2008001795A1
Authority
CL
Chile
Prior art keywords
par1
antagonist
treatment
atrial fibrilation
fibrilation
Prior art date
Application number
CL200801795A
Other languages
English (en)
Inventor
Michel Le Grand Bruno Le Perez
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of CL2008001795A1 publication Critical patent/CL2008001795A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200801795A 2007-06-19 2008-06-17 Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial. CL2008001795A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755848A FR2917622B1 (fr) 2007-06-19 2007-06-19 Utilisation d'un antagoniste par1 dans le traitement de la fibrillation atriale.

Publications (1)

Publication Number Publication Date
CL2008001795A1 true CL2008001795A1 (es) 2008-10-10

Family

ID=38973629

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200801795A CL2008001795A1 (es) 2007-06-19 2008-06-17 Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial.

Country Status (6)

Country Link
AR (1) AR067061A1 (es)
CL (1) CL2008001795A1 (es)
FR (1) FR2917622B1 (es)
PA (1) PA8784901A1 (es)
TW (1) TW200908977A (es)
WO (1) WO2008155335A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902427B1 (fr) * 2006-06-19 2008-08-22 Pierre Fabre Medicament Sa Derives de phenylpentadienoyle
FR2902426B1 (fr) * 2006-06-19 2008-09-05 Pierre Fabre Medicament Sa Derives de cinnamoyl-piperazine
CN104478782B (zh) * 2015-01-13 2016-03-16 佛山市赛维斯医药科技有限公司 一类含烷氧苯基和二烯氟代金刚烷结构的化合物和用途
CN104496879A (zh) * 2015-01-13 2015-04-08 佛山市赛维斯医药科技有限公司 一种含腈基苯和二烯氟代金刚烷结构的化合物和用途
CN104478781A (zh) * 2015-01-13 2015-04-01 佛山市赛维斯医药科技有限公司 二烯金刚烷类化合物、其制备方法和用途
CN104447485A (zh) * 2015-01-13 2015-03-25 佛山市赛维斯医药科技有限公司 一种含腈基苯和二烯金刚烷结构的化合物、其制备方法和用途
TR201601548A2 (tr) * 2016-02-05 2018-03-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Vorapaksar ve metoprololün bi̇r farmasöti̇k kompozi̇syonu
WO2017134200A1 (en) * 2016-02-05 2017-08-10 Sanovel Ilac Sanayi Ve Ticaret A.S. A novel pharmaceutical composition of vorapaxar and metoprolol
KR102268589B1 (ko) * 2019-04-29 2021-06-24 사회복지법인 삼성생명공익재단 단백질분해효소 활성 수용체 매개 신호전달 경로의 활성을 이용한 세포외 소포의 고효율 생성능을 갖는 줄기세포의 선별방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61106564A (ja) * 1984-10-30 1986-05-24 Terumo Corp 不飽和脂肪酸アミド誘導体およびこれを含有する血小板凝集抑制剤
JPS61137866A (ja) * 1984-12-07 1986-06-25 Terumo Corp イミダゾ−ル誘導体およびこれを含有する血小板凝集抑制剤

Also Published As

Publication number Publication date
TW200908977A (en) 2009-03-01
PA8784901A1 (es) 2009-01-23
AR067061A1 (es) 2009-09-30
FR2917622B1 (fr) 2009-10-23
WO2008155335A1 (en) 2008-12-24
FR2917622A1 (fr) 2008-12-26

Similar Documents

Publication Publication Date Title
LTC2340031I2 (lt) Gdf gaudyklės, skirtos naudoti anemijos gydymui
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
CL2008001795A1 (es) Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial.
BRPI0920216A2 (pt) forma de dosagem intraoral em múltiplas porções e uso das mesmas
BRPI0919438A2 (pt) mistura de poliésteres, e, uso das misturas de poliésteres
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BRPI0821668A2 (pt) Uso
DK2300609T3 (da) Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
BRPI0915299A2 (pt) poliamida, composição compreendendo tal poliamida e utilização das mesmas
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI0807908A2 (pt) Melhoramentos em composições medicinais.
BRPI0909769A2 (pt) Composição não-viva contendo carboidrato, e, uso da mesma
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
BRPI0907365A2 (pt) Composição antimicrobiana e uso
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0818766A2 (pt) N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
BRPI0919794A2 (pt) dispositivo para uso intracorpóreo, e, composto
CL2008000110A1 (es) Uso de compuestos derivados de piranona sustituidos para el tratamiento del sindrome metabolico; y compuestos derivados de piranona sustituidos.
CL2013000502A1 (es) Compuestos derivados de-2-(1-(2(2carbonil - etil) bencil) pirrolidin-2il)-n- alquiloxazol -4 carboxamida; uso en el tratamiento de enfermedades involucrada con la respuesta anttinflamatoria en receptores de prostaglandina.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
FR2930124B1 (fr) Meuble demontable
SMT201600217B (it) Furancarbossamidi sostituite e loro uso
BRPI0919816A2 (pt) uso compostos benzoxazólicos no tratamento de malária
BR112013010061A2 (pt) "composição farmacêutica, composição e uso"